IgA Nephropathy: Diagnostic Pathology and Prognostic Features Pathological Diagnosis IgA nephropathy (IgAN) is definitively diagnosed through renal biopsy with the following characteristic ...

American Kidney Fund: “IgA nephropathy.” Journal of the American Society of Nephrology: “Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States ...

The new Oxford classification of IgA nephropathy has been developed as ... widely used International Society of Nephrology and Renal Pathology Society (ISN/RPS) classification of lupus nephritis ...

Immunoglobulin A nephropathy (also known as IgA nephropathy or Berger's disease) is a condition that causes IgA antibodies to accumulate in the kidneys—leading to damage that affects their blood ...

Fibroblast activating protein inhibitor (FAPI) PET/CT imaging may be a non-invasive modality to monitor IgA nephropathy (IgAN) progression, preliminary study results suggest.

The FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary ...

The Food and Drug Administration (FDA) has granted accelerated approval to Vanrafia ® (atrasentan) to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid ...

Astrasentan becomes the first and only endothelin A receptor antagonist to focus on proteinuria reduction in primary ...

In a new study, a joint study by Tokyo University of Science and Juntendo University researchers has become the first to demonstrate the presence of IgA autoantibodies that bind to a specific ...

However, about 30% to 40% of those with IgA nephropathy develop kidney failure 20 to 30 years after symptom onset. Early ...

But, since IgA nephropathy may run in families, genetic and environmental factors probably contribute to developing the disease. Kidney disease usually cannot be cured. Once the tiny filtering ...